TODOROVIĆ, S. RISK OF COVID-19 INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB – A SINGLE CENTER EXPERIENCE. Acta medicae Medianae, v. 62, n. 3, 17 Nov.2023.